Kyinno Bio
PrivateLast Round
Series B
Dec 15, 2025
Total Funding Raised
$58.8M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Kyinno Bio is a biotechnology company that operates as a preclinical contract research organization (CRO) specializing in customized services, including in vitro and in vivo pharmacology, cell line engineering, and antibody discovery to accelerate cancer drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kyinno Bio Comparables
Compare Kyinno Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Taizhou Baiying Biotechnology | 83% | |
| Creative Biolabs | 82% | |
| PharmaLegacy | 81% |
Kyinno Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 15, 2025 | ||||
| Series A Extension | Nov 29, 2021 | ||||
| Series A | Apr 1, 2021 | ||||
| Angel | Jul 10, 2017 |
Kyinno Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series B |
| Beijing E-Town International Investment & Development Co., Ltd. | Series B |
| Renai Capital | Series B |
| Qianshan Capital Management Co., Ltd. | Series A |
| YuanBio Venture Capital | Series A |
| Beijing Pharmaceutical and Health Industry Investment Fund | Series B |
| Yuanhui Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2026
Open roles increased from 0 to 8, representing 400% of headcount.
- Dec 15, 2025
$36M round led by Beijing E-Town International Investment & Development Co., Ltd.
Kyinno Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kyinno Bio's valuation, stock price, and market status.
Is Kyinno Bio a public or private company?
Kyinno Bio is a private company.
What is the current stock price of Kyinno Bio?
Kyinno Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Kyinno Bio worth (valuation)?
Valuation information for Kyinno Bio is not publicly available.
Can I buy Kyinno Bio stock?
Kyinno Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kyinno Bio's last funding round?
Kyinno Bio's most recent funding round was Series B on December 15, 2025.
Who are the main investors in Kyinno Bio?
Key investors in Kyinno Bio include BioTrack Capital, Beijing E-Town International Investment & Development Co., Ltd., Beijing Pharmaceutical and Health Industry Investment Fund, MPCi.
Will Kyinno Bio IPO soon?
No public IPO plans have been announced for Kyinno Bio.
How can I track Kyinno Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kyinno Bio's secondary market activity and sign up for updates.